Luc Duchateau
638 works · 17,701 citations · h-index 63
Top works
- Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902
- Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
- Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
- Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials
- Severity of E. coli mastitis is mainly determined by cow factors
- Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
- The Frailty Model
- Calculating disability-adjusted life years to quantify burden of disease
- Knowledge, Health Seeking Behavior and Perceived Stigma towards Tuberculosis among Tuberculosis Suspects in a Rural Community in Southwest Ethiopia
- Individual Patient- versus Literature-Based Meta-analysis of Survival Data
- Breast-conserving therapy for paget disease of the nipple
- Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
- DALY calculation in practice: a stepwise approach
- Multiple Insecticide Resistance: An Impediment to Insecticide-Based Malaria Vector Control Program
- VERTEBRAL HEART SIZE RANGES SPECIFIC FOR WHIPPETS
- Malaria and water resource development: the case of Gilgel-Gibe hydroelectric dam in Ethiopia
- In Vitro Effects of Nonesterified Fatty Acids on Bovine Neutrophils Oxidative Burst and Viability
- Improved survival after one course of perioperative chemotherapy in early breast cancer patients
- Exemestane (Aromasin) is active and well tolerated as first-line hormonal therapy (HT) of metastatic breast cancer (MBC) patients (pts): results of a randomized phase II trial
- Associations between anti-Fasciola hepatica antibody levels in bulk-tank milk samples and production parameters in dairy herds